A detailed history of Abrdn PLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Abrdn PLC holds 371,089 shares of VRTX stock, worth $172 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
371,089
Previous 371,402 0.08%
Holding current value
$172 Million
Previous $174 Million 0.86%
% of portfolio
0.32%
Previous 0.34%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$460.0 - $505.78 $143,980 - $158,309
-313 Reduced 0.08%
371,089 $173 Million
Q2 2024

Aug 09, 2024

SELL
$392.81 - $485.53 $79.7 Million - $98.5 Million
-202,795 Reduced 35.32%
371,402 $174 Million
Q1 2024

May 08, 2024

SELL
$407.69 - $446.08 $2.78 Million - $3.04 Million
-6,821 Reduced 1.17%
574,197 $240 Million
Q4 2023

Jan 31, 2024

BUY
$343.0 - $410.68 $132 Million - $158 Million
384,730 Added 196.0%
581,018 $236 Million
Q3 2023

Nov 06, 2023

SELL
$338.18 - $362.46 $283,056 - $303,379
-837 Reduced 0.42%
196,288 $68.3 Million
Q2 2023

Jun 20, 2024

SELL
$314.42 - $351.91 $553,379 - $619,361
-1,760 Reduced 0.88%
197,125 $69.4 Million
Q2 2023

Aug 04, 2023

SELL
$314.42 - $351.91 $553,379 - $619,361
-1,760 Reduced 0.88%
197,125 $69.4 Million
Q1 2023

Jun 20, 2024

BUY
$283.23 - $323.1 $4.27 Million - $4.87 Million
15,069 Added 8.2%
198,885 $62.7 Million
Q1 2023

Apr 28, 2023

BUY
$283.23 - $323.1 $4.27 Million - $4.87 Million
15,069 Added 8.2%
198,885 $62.7 Million
Q4 2022

Jun 20, 2024

SELL
$285.76 - $321.48 $112 Million - $125 Million
-390,381 Reduced 67.99%
183,816 $53.1 Million
Q4 2022

Feb 09, 2023

SELL
$285.76 - $321.48 $856,994 - $964,118
-2,999 Reduced 1.61%
183,816 $53.1 Million
Q3 2022

Nov 10, 2022

BUY
$273.83 - $305.53 $22.1 Million - $24.7 Million
80,841 Added 76.28%
186,815 $54.1 Million
Q2 2022

Aug 05, 2022

BUY
$234.96 - $292.55 $2.25 Million - $2.81 Million
9,591 Added 9.95%
105,974 $29.8 Million
Q1 2022

May 04, 2022

BUY
$221.42 - $260.97 $389,699 - $459,307
1,760 Added 1.86%
96,383 $25.1 Million
Q4 2021

Feb 08, 2022

SELL
$177.01 - $223.45 $74.4 Million - $93.9 Million
-420,216 Reduced 81.62%
94,623 $20.8 Million
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $2.29 Million - $2.56 Million
-12,600 Reduced 2.39%
514,839 $94.3 Million
Q2 2021

Aug 10, 2021

BUY
$187.49 - $221.1 $80.7 Million - $95.1 Million
430,311 Added 443.03%
527,439 $106 Million
Q1 2021

May 06, 2021

BUY
$207.02 - $241.31 $1.42 Million - $1.65 Million
6,845 Added 7.58%
97,128 $20.9 Million
Q4 2020

Feb 10, 2021

BUY
$207.01 - $276.09 $655,186 - $873,824
3,165 Added 3.63%
90,283 $21.3 Million
Q3 2020

Oct 21, 2020

SELL
$255.65 - $303.1 $3.17 Million - $3.76 Million
-12,406 Reduced 12.47%
87,118 $23.7 Million
Q2 2020

Aug 10, 2020

SELL
$225.48 - $295.8 $349,268 - $458,194
-1,549 Reduced 1.53%
99,524 $28.9 Million
Q1 2020

May 13, 2020

SELL
$199.77 - $247.81 $4.9 Million - $6.07 Million
-24,504 Reduced 19.51%
101,073 $24.1 Million
Q4 2019

Feb 18, 2020

SELL
$166.71 - $223.91 $312,747 - $420,055
-1,876 Reduced 1.47%
125,577 $27.5 Million
Q3 2019

Nov 13, 2019

SELL
$166.23 - $187.09 $8.99 Million - $10.1 Million
-54,111 Reduced 29.8%
127,453 $21.6 Million
Q2 2019

Aug 13, 2019

SELL
$164.61 - $190.37 $17.9 Million - $20.7 Million
-108,875 Reduced 37.49%
181,564 $33.3 Million
Q1 2019

May 14, 2019

SELL
$163.73 - $194.7 $70.7 Million - $84 Million
-431,610 Reduced 59.78%
290,439 $53.4 Million
Q4 2018

Feb 12, 2019

SELL
$151.91 - $192.21 $25 Million - $31.6 Million
-164,557 Reduced 18.56%
722,049 $117 Million
Q3 2018

Nov 13, 2018

SELL
$167.73 - $192.74 $43.3 Million - $49.8 Million
-258,307 Reduced 22.56%
886,606 $171 Million
Q2 2018

Aug 09, 2018

BUY
$145.72 - $169.96 $118 Million - $137 Million
807,086 Added 238.91%
1,144,913 $195 Million
Q1 2018

May 15, 2018

BUY
$151.6 - $177.13 $25.8 Million - $30.2 Million
170,495 Added 101.89%
337,827 $55.1 Million
Q4 2017

Feb 12, 2018

BUY
$137.28 - $155.55 $13.2 Million - $14.9 Million
95,825 Added 134.01%
167,332 $25.1 Million
Q3 2017

Nov 14, 2017

BUY
$148.13 - $162.24 $10.6 Million - $11.6 Million
71,507
71,507 $10.9 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.